Novavax, Inc. (NASDAQ:NVAX - Free Report) - Analysts at Zacks Research boosted their Q1 2027 earnings per share (EPS) estimates for shares of Novavax in a research report issued to clients and investors on Tuesday, July 7th. Zacks Research analyst Team now anticipates that the biopharmaceutical comp